BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Xu YM, Li ZW, Wu HY, Fan XS, Sun Q. Mixed serous-neuroendocrine neoplasm of the pancreas: A case report and review of the literature. World J Clin Cases 2019; 7(23): 4119-4129 [PMID: 31832417 DOI: 10.12998/wjcc.v7.i23.4119] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
Number Citing Articles
1 Vanderveldt H, Singhi AD. Mixed Serous Cell Neuroendocrine Neoplasm of the Pancreas, Demonstrating a Biphasic Developmental Origin, Identified Through Genomic Mutational Analysis. Pancreas 2022;51:e17-8. [DOI: 10.1097/mpa.0000000000001977] [Reference Citation Analysis]
2 Yadav RS, Pokharel A, Shrestha S, Pokharel A, Gaire D, Pradhan S, Kansakar PBS. Pancreatic Neuroendocrine Tumor with Benign Serous Cystadenoma: A Rare Entity. Case Rep Oncol Med 2021;2021:9979998. [PMID: 34395004 DOI: 10.1155/2021/9979998] [Reference Citation Analysis]
3 Laks S, van Leeuwaarde R, Patel D, Keutgen XM, Hammel P, Nilubol N, Links TP, Halfdanarson TR, Daniels AB, Tirosh A; Pancreatic Manifestations Recommendations Development Subcommittee of the VHL Alliance. Management recommendations for pancreatic manifestations of von Hippel-Lindau disease. Cancer 2021. [PMID: 34735022 DOI: 10.1002/cncr.33978] [Reference Citation Analysis]